Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
AmUr2hDf5asPkgt6
Listen
